BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen K, Deng X, Yang Z, Yu D, Zhang X, Zhang J, Xie D, He Z, Cheng D. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study. Expert Rev Gastroenterol Hepatol 2020;14:757-64. [PMID: 32552040 DOI: 10.1080/17474124.2020.1784726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Jiang Q, Yue C, Wang Q. Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study. Int J Gen Med 2021;14:10303-14. [PMID: 34992445 DOI: 10.2147/IJGM.S341405] [Reference Citation Analysis]
2 Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data. BMC Cancer 2021;21:532. [PMID: 33971833 DOI: 10.1186/s12885-021-08249-x] [Reference Citation Analysis]
3 Chen L, Tang K, Wang S, Chen D, Ding K. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study. Cancer Control 2021;28:10732748211026668. [PMID: 34155922 DOI: 10.1177/10732748211026668] [Reference Citation Analysis]
4 Tong Y, Huang Z, Hu C, Chi C, Lv M, Song Y. Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients. Biomed Res Int 2020;2020:9501760. [PMID: 33282957 DOI: 10.1155/2020/9501760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]